chronic kidney disease	is risk factor for	cardiovascular disease
chronic kidney disease	is risk factor for	mortality
chronic kidney disease	is risk factor for	hospitalization
chronic kidney disease	is risk factor for	infection
diabetes mellitus	is major cause of	chronic kidney disease
hypertension	is major cause of	chronic kidney disease
albuminuria	is marker for	kidney damage
albuminuria	predicts	CKD progression
eGFR	is measure of	kidney function
creatinine	is biomarker for	kidney function
CKD	progresses to	end-stage renal disease
CKD	increases risk of	cardiovascular events
CKD	increases risk of	heart failure
CKD	increases risk of	arrhythmia
CKD	increases risk of	stroke
CKD	increases risk of	infection
CKD	predisposes to	anemia
anemia	is common in	CKD
anemia	causes	fatigue
hyperkalemia	occurs in	CKD
hyperphosphatemia	occurs in	CKD
hypocalcemia	occurs in	CKD
metabolic acidosis	occurs in	CKD
bone mineral disorder	is complication of	CKD
renal osteodystrophy	is complication of	CKD
secondary hyperparathyroidism	occurs in	CKD
parathyroid hormone	regulates	calcium homeostasis
PTH	is elevated in	CKD
ferritin	is marker of	iron stores
iron deficiency	is common in	CKD
iron supplementation	treats	anemia
erythropoietin-stimulating agent	treats	anemia
ACE inhibitors	reduce	proteinuria
angiotensin receptor blockers	reduce	proteinuria
diuretic therapy	is used for	edema in CKD
phosphate binders	treat	hyperphosphatemia
calcium carbonate	used for	hyperphosphatemia
calcitriol	used for	CKD-related bone disease
vitamin D deficiency	occurs in	CKD
kidney transplantation	is option for	CKD
dialysis	is treatment for	CKD
hemodialysis	is modality of	dialysis
peritoneal dialysis	is modality of	dialysis
renal replacement therapy	is for	CKD
renal replacement therapy	includes	dialysis
end-stage renal disease	requires	renal replacement therapy
vascular access	required for	hemodialysis
bone fracture	risk increases with	CKD
vascular calcification	associated with	CKD
chronic kidney disease	increases prevalence of	sleep apnea
protein-energy wasting	occurs with	CKD
malnutrition	is associated with	CKD outcomes
uremic toxins	accumulate in	CKD
uremia	is complication of	CKD
creatinine clearance	declines with	CKD progression
glomerular filtration rate	declines with	CKD progression
urine protein	is marker of	kidney damage
microalbuminuria	indicates	CKD progression
proteinuria	indicates	kidney damage
urea	accumulates in	CKD
sodium balance	disrupted in	CKD
volume overload	occurs in	CKD
anemia of CKD	treated with	erythropoietin-stimulating agent
ferritin	correlates with	iron stores
secondary hyperparathyroidism	worsens	CKD
aging	increases risk of	CKD progression
dietary restriction	recommended for	CKD
protein restriction	implemented in	CKD
potassium restriction	recommended in	CKD
sodium restriction	recommended in	CKD
phosphorus restriction	recommended in	CKD
lipid disorders	is common in	CKD
statin therapy	reduces	cardiovascular events in CKD
cardiovascular disease	coexists with	CKD
renal anemia	is feature of	CKD
glycemic control	improves	CKD outcomes
BP control	improves	CKD outcomes
nephrology consultation	improves	CKD outcomes
education	reduces	CKD complications
uric acid	accumulates in	CKD
bone turnover markers	altered in	CKD
parathyroid gland	enlarges in	CKD
renal osteodystrophy	managed with	vitamin D analogs
calcium	regulates	PTH secretion
PTH	drives	bone turnover
anemia	worsens with	CKD progression
dietary phosphate restriction	reduces	hyperphosphatemia
dietary sodium restriction	reduces	hypertension in CKD
protein-energy wasting	increases	CKD mortality
CKD progression	correlates with	hospitalization rate
kidney function	declines with	aging
nephrology care	reduces	readmission
end-stage kidney disease	leads to	dialysis dependence
kidney failure	requires	dialysis
uremic symptoms	occur in	advanced CKD
anemia	contributes to	fatigue
iron therapy	improves	anemia in CKD
protein-bound toxins	accumulate in	CKD
phosphate metabolism	disrupted in	CKD
renal function	assessed by	serum creatinine
